Childhood Acute Lymphoblastic Leukemia  >>  Synagis (palivizumab)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Synagis (palivizumab) / SOBI
NCT00014391: Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

Completed
3
US
palivizumab, ribavirin
Fred Hutchinson Cancer Center, National Cancer Institute (NCI)
Cancer
10/01
10/01

Download Options